Related Tags >> FDA ADHD milestones pharmaceuticals

Shire News

Most Popular Shire Story

ALSO NOTED: CRO market hits $14B; Merck ends BioXell pact; and much more...

July 20, 2007 — 6:59am ET

> Merck has ended its collaboration with BioXell on its sepsis drug TREM-1. BioXell says it will seek another company with which to partner on the drug. Report > Shire... Read more...

Shire Press Releases

Shire Announces Results from a Multidisciplinary Analysis of the Drug Release Profiles of LIALDA (mesalamine) and Asacol
PRESS RELEASE: Amicus Therapeutics, Inc. and Shire Pharmaceuticals Group Enter Into $440 Million ex-US Licensing Agreement
PRESS RELEASE: Shire Pharmaceuticals Group's Fosrenol Does Not Meet Main Goal of Trial
PRESS RELEASE: Shire Voluntarily Withdraws a Limited Portion of Daytrana (Methylphenidate Transdermal System) Patches

Latest Headlines

Shire to buy Jerini in $521M deal
July 3, 2008
Mixed data for Renovo's scarring therapy
March 3, 2008
Shire, Amicus forge $440M pact
November 8, 2007
ALSO NOTED: Big CEO turnover at Big Pharma; New company takes on RNAi field; Shire hunts for buyouts; and much more...
November 2, 2007
3. Shire and Renovo
September 11, 2007
Shire to Massachusetts: Pass incentive bill now
August 31, 2007
ALSO NOTED: Avandia gets Black Box Warning; Shire licensing deal complete; Pittsburgh companies gain financing; and much more..
August 15, 2007
Noven garners $25M payday on sales milestone
July 31, 2007
ALSO NOTED: CRO market hits $14B; Merck ends BioXell pact; and much more...
July 20, 2007
Progeria trial underscores challenge of rare diseases
January 29, 2007
SPOTLIGHT: Avexa gains rights to HIV drug
January 22, 2007
Press Release: FDA Approves Shire's Lialda
January 17, 2007
FDA approves Shire's new ulcerative colitis drug
January 16, 2007
ALSO NOTED: Shire drug gets second approvable letter; Galapagos acquires ProStrakan sub; FDA asks Allergan for more data; and m
December 21, 2006
Shire, New River shares surge on FDA approval
October 8, 2006
FDA approves Shire's pricey Elaprase
July 24, 2006
FDA delays decision on Shire's Elaprase
May 16, 2006
ALSO NOTED: FDA delays Adderall decision;Actavis raises Pliva bid; and much more...
April 20, 2006
FDA approves Daytrana ADHD patch
April 6, 2006
Shire says Daytrana action is looming
March 9, 2006

Paid Research Reports